Powered by

Anavex Life Sciences Announces the Appointment of Walter E Kaufmann, MD as Chief Medical Officer

Jan 02, 2019 - GlobeNewswire
Board and Executive Moves

NEW YORK, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases including Alzheimer's disease, Parkinson's disease, Rett syndrome and other central nervous system (CNS) diseases, today announced the appointment of Walter E Kaufmann, MD to Chief Medical Officer (CMO).

Dr. Walter Kaufmann'...